Pioglitazone-Induced Progressive Pancytopenia

Abstract

Get full access to this article

View all access options for this article.

References

Berna

, Glass

, Mahankali

. Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in type II diabetes mellitus. Clin Pharmacol Ther 2007; 82:275–81.

Karakurt

, Kargili

, Kasapoglu

. Pioglitazone induced reversible pancytopenia. Exp Clin Endocrinol Diabetes 2010; 118:96–7.

Naranjo

, Busto

, Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239–45.

Pioglitazone. DRUGDEX System. Greenwood Village, CO: Thomson Micromedex, expires 2010 Dec 31 (accessed 2010 Sept 10).

Saiki

, Hatta

, Yamazaki

. Pioglitazone inhibits the growth of human leukaemia cell lines and primary leukaemia cells while sparing normal hematopoietic stem cells. Int J Oncology 2006; 29:437–43.